Tag Archives: Molecular Templates

Back in October, we published this piece, outlining our thoughts on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD). At the time, the company has just reported the discontinuation of its lead development program, and had collapsed on the back...

Sign Up Now For Our FREE Small Cap Newsletter